CME Group Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

CME Group wird ein jährliches Gewinn- und Umsatzwachstum von 3.5% bzw. 4.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 3.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12.9% betragen.

Wichtige Informationen

3.7%

Wachstumsrate der Gewinne

3.5%

EPS-Wachstumsrate

Capital Markets Gewinnwachstum	14.7%
Wachstumsrate der Einnahmen	4.0%
Zukünftige Eigenkapitalrendite	13.4%
Analystenabdeckung	Good
Zuletzt aktualisiert	26 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

Apr 26

Recent updates

Looking For (Special) Dividends? CME Group Remains One Of My Best Ideas In Finance

May 25

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

May 21

Gunning For CME's Golden Goose

May 01

Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

Apr 26

CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty

Apr 15

CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates

Mar 27

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Mar 05

CME Group Is One Of My Favorite High-Yielding Stocks Today

Feb 29

CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15

Feb 20

CME Group: Buying 'The House' Proves A Winning Strategy

Feb 14

CME Group: Uncertainty In The World Equals Higher Revenue Growth

Feb 04

Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely

Dec 27

Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors

Nov 14

We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation

Apr 28

CME Group (NASDAQ:CME) Is Paying Out A Larger Dividend Than Last Year

Dec 15

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:CME - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	6,503	3,680	4,003	4,125	10
12/31/2025	6,210	3,513	3,800	3,916	15
12/31/2024	6,057	3,406	3,686	3,769	14
6/30/2024	5,788	3,262	3,492	3,571	N/A
3/31/2024	5,616	3,157	3,363	3,444	N/A
12/31/2023	5,569	3,186	3,377	3,454	N/A
9/30/2023	5,338	3,011	3,311	3,391	N/A
6/30/2023	5,228	2,942	3,108	3,192	N/A
3/31/2023	5,104	2,828	3,078	3,159	N/A
12/31/2022	5,009	2,657	2,966	3,056	N/A
9/30/2022	4,833	2,633	2,650	2,743	N/A
6/30/2022	4,715	2,889	2,616	2,717	N/A
3/31/2022	4,657	2,745	2,477	2,599	N/A
12/31/2021	4,690	2,617	2,275	2,402	N/A
9/30/2021	4,630	2,435	2,225	2,394	N/A
6/30/2021	4,600	1,920	1,888	2,074	N/A
3/31/2021	4,603	1,913	2,378	2,561	N/A
12/31/2020	4,884	2,105	2,518	2,716	N/A
9/30/2020	4,911	2,151	2,581	2,775	N/A
6/30/2020	5,109	2,375	3,071	3,274	N/A
3/31/2020	5,200	2,386	2,521	2,761	N/A
12/31/2019	4,868	2,117	2,427	2,673	N/A
9/30/2019	4,959	2,033	2,229	2,464	N/A
6/30/2019	4,588	1,808	2,027	2,236	N/A
3/31/2019	4,377	1,860	2,137	2,285	N/A
12/31/2018	4,309	1,962	2,324	2,441	N/A
9/30/2018	3,973	4,516	2,301	2,391	N/A
6/30/2018	3,959	4,413	2,242	2,316	N/A
3/31/2018	3,824	4,262	N/A	2,057	N/A
12/31/2017	3,645	4,063	N/A	1,751	N/A
9/30/2017	3,658	1,498	N/A	1,801	N/A
6/30/2017	3,609	1,662	N/A	1,773	N/A
3/31/2017	3,590	1,566	N/A	1,732	N/A
12/31/2016	3,595	1,534	N/A	1,732	N/A
9/30/2016	3,496	1,452	N/A	1,607	N/A
6/30/2016	3,505	1,340	N/A	1,591	N/A
3/31/2016	3,418	1,284	N/A	1,626	N/A
12/31/2015	3,327	1,247	N/A	1,533	N/A
9/30/2015	3,354	1,262	N/A	1,644	N/A
6/30/2015	3,266	1,192	N/A	1,414	N/A
3/31/2015	3,178	1,191	N/A	1,327	N/A
12/31/2014	3,113	1,127	N/A	1,291	N/A
9/30/2014	2,958	1,014	N/A	1,171	N/A
6/30/2014	2,911	960	N/A	1,066	N/A
3/31/2014	2,990	1,008	N/A	1,268	N/A
12/31/2013	2,931	977	N/A	1,281	N/A
9/30/2013	2,905	951	N/A	1,221	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CMEDas prognostizierte Gewinnwachstum (3.5% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: CMEDie Erträge des Unternehmens (3.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.8% pro Jahr).

Hohe Wachstumserträge: CMEDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: CMEDie Einnahmen des Unternehmens (4.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.6% pro Jahr).

Hohe Wachstumseinnahmen: CMEDie Einnahmen des Unternehmens (4.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: CMEDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12.9%).

CME Group Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

Recent updates

CME Group Inc. to Report Q3, 2024 Results on Oct 23, 2024

Insider recently sold US$1.6m worth of stock

CME Group: Poised To Benefit From Rate Cuts; Continues To Innovate

Upcoming dividend of US$1.15 per share

CME Group to Launch Bitcoin Friday Futures on September 30, 2024

CME Group Has It All - Growth, Dividend Growth, And Value

CME, S&P Reportedly Explore Sale of Joint Venture OSTTRA

Dividend of US$1.15 announced

CME Group Inc. Declares Third-Quarter Dividend, Payable on September 25, 2024

Down But Not Out: Why CME Group Remains One Of My Favorite Dividend Stocks

Second quarter 2024 earnings: Revenues and EPS in line with analyst expectations

CME Group and CF Benchmark to Launch Two New Cryptocurrency Reference Rates and Real-Time Indices on July 29, 2024

CME Group Inc. Names Mike Dennis as Global Head of Fixed Income

CME Group Inc.'s (NASDAQ:CME) Price Is Out Of Tune With Earnings

CME Group: FMX Market Entry Poses Real Risk

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

CME Group Inc. Appoints John Ricci as Managing Director and Global Head of Agricultural Products

Upcoming dividend of US$1.15 per share

CME Group Inc. to Report Q2, 2024 Results on Jul 24, 2024

Looking For (Special) Dividends? CME Group Remains One Of My Best Ideas In Finance

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Dividend of US$1.15 announced

Insider recently sold US$1.5m worth of stock

CME Group Announces to Expand Its Suite of Short-Term WTI Crude Oil Options

Chairman & CEO recently sold US$8.4m worth of stock

Gunning For CME's Golden Goose

Chairman & CEO notifies of intention to sell stock

Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

First quarter 2024 earnings: Revenues and EPS in line with analyst expectations

CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty

CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates

CME Group Inc. to Report Q1, 2024 Results on Apr 24, 2024

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Now 20% overvalued after recent price rise

Full year 2023 earnings: EPS exceeds analyst expectations

CME Group Is One Of My Favorite High-Yielding Stocks Today

Upcoming dividend of US$1.15 per share

CME Group to Launch Micro Euro-Denominated Bitcoin and Ether Futures on March 18

CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15

CME Group Launches Clearing Service for Mexican F-TIIE Overnight Index Swaps

Full year 2023 earnings: EPS exceeds analyst expectations

CME Group: Buying 'The House' Proves A Winning Strategy

Now 23% overvalued after recent price rise

Dividend increased to US$1.15

CME Group Declares Quarterly Dividend, Payable on March 26, 2024

CME Group: Uncertainty In The World Equals Higher Revenue Growth

CME Group to Launch E-mini S&P 500 Equal Weight Futures on February 26

Saudi Tadawul Group Holding Company (SASE:1111) entered into a binding agreement to acquire unknown minority stake in Dubai Mercantile Exchange Limited from a group of sellers.

CME Group to Launch Longer-Dated Event Contracts on January 29

Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely

CME Group Inc. to Report Q4, 2023 Results on Feb 14, 2024

Upcoming dividend of US$5.25 per share at 4.5% yield

CME Group Inc., Annual General Meeting, May 09, 2024

CME Group Declares Annual Variable Dividend, Payable on January 18, 2024

Insider recently sold US$2.8m worth of stock

CME Group to Launch FX Spot+ to Connect Otc and Futures Liquidity

Upcoming dividend of US$1.10 per share at 4.1% yield

Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors

CME Group Inc. Declares a Fourth-Quarter Dividend, Payable on December 28, 2023

CME Group Expands Suite of Short-Term Options on U.S. Treasury Futures

Third quarter 2023 earnings: EPS misses analyst expectations

CME Group Inc. to Report Q3, 2023 Results on Oct 25, 2023

CME Group to Launch T-Bill Futures on October 2, as U.S. Treasury Futures Open Interest Hits Record 19.8 Million Contracts

Upcoming dividend of US$1.10 per share at 4.4% yield

Chairman & CEO notifies of intention to sell stock

Insider recently sold US$1.3m worth of stock

Chief Information Officer notifies of intention to sell stock

CME Group Inc. Declares Third-Quarter Dividend, Payable on September 27, 2023

New minor risk - Insider selling

Chief Information Officer recently sold US$2.0m worth of stock

Second quarter 2023 earnings: EPS in line with analyst expectations despite revenue beat

CME Group Inc. to Report Q2, 2023 Results on Jul 26, 2023

Upcoming dividend of US$1.10 per share at 5.0% yield

CME Group Inc. Elects Harold Ford and Duffy, Kathryn Benesh as Directors